SANTIS PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
SANTIS PHARMA
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€1.2m
2024 · €631,403+€592,444
Equity
€640,449
2024 · €5.3m-€4.7m
Cash
€99,050
2024 · €150,259-€51,208
Balance sheet total
€8.7m
2024 · €12.2m-€3.5m
Largest movements
Assets
- Receivables within one year -€1.8m
down €1.8m (-81.5%), from €2.2m to €410,962
of which Trade receivables: -€979,679
- Financial fixed assets -€1.6m
down €1.6m (-19.7%), from €8.3m to €6.7m
of which Affiliated companies: -€1.6m
Equity and liabilities
- Other debts +€2.9m
up €2.9m (+1484949.8%), from €195 to €2.9m
- Reserves -€2.7m
down €2.7m (-96.6%), from €2.8m to €96,143
of which Distributable reserves: -€2.7m
- Profit (loss) carried forward -€2.0m
no longer reported in 2025 (was €2.0m)
- Trade debts -€1.5m
down €1.5m (-87.0%), from €1.7m to €219,173
- Debts after one year -€587,594
down €587,594 (-13.9%), from €4.2m to €3.6m
Income statement
- Services and other goods -€1.3m
down €1.3m (-39.7%), from €3.2m to €1.9m
- Goods and materials -€729,145
down €729,145 (-5.6%), from €13.1m to €12.4m
of which Change in stocks: decrease (increase): -€985,517
- Turnover -€661,459
down €661,459 (-3.6%), from €18.6m to €17.9m
- Staff costs +€660,203
up €660,203 (+49.6%), from €1.3m to €2.0m
- Taxes +€209,136
up €209,136 (+96.9%), from €215,721 to €424,857
of which Taxes: +€209,071
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€631,403
Turnover
-€661,459
Other operating income
+€97,123
Goods and materials
+€729,145
Services and other goods
+€1.3m
Staff costs
-€660,203
Depreciation
-€14,406
Write-downs
+€35,654
Other operating charges
+€16,148
Other operating items
+€13,412
Financial income
-€47,032
Financial charges
+€29,573
Taxes
-€209,136
Result 2025
€1.2m
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€5.1m
Investment
+€1.4m
Financing
-€6.6m
Cash 2024
€150,259
From operations (derived)
+€5.1m
Net result for the year
+€1.2m
Depreciation
+€220,913
Smaller working-capital items
-€7,324
Receivables within one year
+€1.8m
Deferred charges and accrued income
-€18,810
Trade debts
-€1.5m
Tax, wage and social debts
+€417,577
Other debts
+€2.9m
Investment (derived)
+€1.4m
Investment in fixed assets (net)
+€1.4m
Financing
-€6.6m
Debts after one year
-€587,594
Current portion of long-term debt
-€154,188
Short-term financial debts
+€50,489
Contributions, distributions and other
-€5.9m
Cash 2025
€99,050
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €12,160,777 | €8,654,316 | -€3.5m | -28.8% |
| Fixed assets | 21/28 | €9,048,194 | €7,388,589 | -€1.7m | -18.3% |
| Intangible fixed assets | 21 | €112,659 | €97,802 | -€14,857 | -13.2% |
| Tangible fixed assets | 22/27 | €654,835 | €638,362 | -€16,474 | -2.5% |
| Furniture and vehicles | 24 | €142,314 | €88,759 | -€53,555 | -37.6% |
| Leasing and similar rights | 25 | - | €4,774 | +€4,774 | |
| Other tangible fixed assets | 26 | €512,522 | €544,829 | +€32,307 | +6.3% |
| Financial fixed assets | 28 | €8,280,700 | €6,652,425 | -€1.6m | -19.7% |
| Affiliated companies | 280/1 | €8,280,700 | €6,652,231 | -€1.6m | -19.7% |
| Amounts receivable | 281 | €8,280,700 | €6,652,231 | -€1.6m | -19.7% |
| Other financial fixed assets | 284/8 | - | €194 | +€194 | |
| Amounts receivable and cash guarantees | 285/8 | - | €194 | +€194 | |
| Current assets | 29/58 | €3,112,583 | €1,265,727 | -€1.8m | -59.3% |
| Stocks and contracts in progress | 3 | €723,648 | €725,124 | +€1,476 | +0.2% |
| Stocks | 30/36 | €723,648 | €725,124 | +€1,476 | +0.2% |
| Goods purchased for resale | 34 | €723,648 | €725,124 | +€1,476 | +0.2% |
| Amounts receivable within one year | 40/41 | €2,226,896 | €410,962 | -€1.8m | -81.5% |
| Trade receivables | 40 | €1,253,691 | €274,012 | -€979,679 | -78.1% |
| Other amounts receivable | 41 | €973,205 | €136,950 | -€836,254 | -85.9% |
| Cash at bank and in hand | 54/58 | €150,259 | €99,050 | -€51,208 | -34.1% |
| Deferred charges and accrued income | 490/1 | €11,780 | €30,590 | +€18,810 | +159.7% |
| Total equity and liabilities | 10/49 | €12,160,777 | €8,654,316 | -€3.5m | -28.8% |
| Equity | 10/15 | €5,291,150 | €640,449 | -€4.7m | -87.9% |
| Contributions | 10/11 | €544,306 | €544,306 | = | 0.0% |
| Reserves | 13 | €2,787,110 | €96,143 | -€2.7m | -96.6% |
| Non-distributable reserves | 130/1 | €42,184 | €42,184 | = | 0.0% |
| Other | 1319 | €42,184 | €42,184 | = | 0.0% |
| Tax-exempt reserves | 132 | €53,959 | €53,959 | = | 0.0% |
| Distributable reserves | 133 | €2,690,967 | - | -€2.7m | |
| Profit (loss) carried forward | 14 | €1,959,734 | - | -€2.0m | |
| Amounts payable | 17/49 | €6,869,627 | €8,013,867 | +€1.1m | +16.7% |
| Amounts payable after more than one year | 17 | €4,224,379 | €3,636,785 | -€587,594 | -13.9% |
| Financial debts | 170/4 | €4,224,379 | €3,636,785 | -€587,594 | -13.9% |
| Credit institutions | 173 | €4,224,379 | €3,636,785 | -€587,594 | -13.9% |
| Amounts payable within one year | 42/48 | €2,638,397 | €4,376,078 | +€1.7m | +65.9% |
| Current portion of amounts payable after more than one year | 42 | €763,112 | €608,924 | -€154,188 | -20.2% |
| Financial debts | 43 | - | €50,489 | +€50,489 | |
| Credit institutions | 430/8 | - | €50,489 | +€50,489 | |
| Trade debts | 44 | €1,691,021 | €219,173 | -€1.5m | -87.0% |
| Suppliers | 440/4 | €1,691,021 | €219,173 | -€1.5m | -87.0% |
| Taxes, remuneration and social security | 45 | €184,069 | €601,646 | +€417,577 | +226.9% |
| Taxes | 450/3 | €1,518 | €182,213 | +€180,696 | +11907.5% |
| Remuneration and social security | 454/9 | €182,552 | €419,433 | +€236,881 | +129.8% |
| Other amounts payable | 47/48 | €195 | €2,895,847 | +€2.9m | +1484949.8% |
| Accrued charges and deferred income | 492/3 | €6,851 | €1,004 | -€5,847 | -85.3% |
| Operating income | 70/76A | €18,785,525 | €18,220,399 | -€565,126 | -3.0% |
| Turnover | 70 | €18,578,590 | €17,917,131 | -€661,459 | -3.6% |
| Other operating income | 74 | €206,145 | €303,268 | +€97,123 | +47.1% |
| Non-recurring operating income | 76A | €790 | - | -€790 | |
| Operating charges | 60/66A | €17,908,312 | €16,524,147 | -€1.4m | -7.7% |
| Goods for resale, raw materials and consumables | 60 | €13,103,210 | €12,374,066 | -€729,145 | -5.6% |
| Purchases | 600/8 | €12,111,917 | €12,368,289 | +€256,372 | +2.1% |
| Change in stocks: decrease (increase) | 609 | €991,293 | €5,776 | -€985,517 | -99.4% |
| Services and other goods | 61 | €3,179,351 | €1,915,726 | -€1.3m | -39.7% |
| Remuneration, social security and pensions | 62 | €1,332,303 | €1,992,506 | +€660,203 | +49.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €206,507 | €220,913 | +€14,406 | +7.0% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €38,171 | €2,517 | -€35,654 | -93.4% |
| Other operating charges | 640/8 | €34,568 | €18,420 | -€16,148 | -46.7% |
| Non-recurring operating charges | 66A | €14,202 | - | -€14,202 | |
| Operating profit (loss) | 9901 | €877,213 | €1,696,252 | +€819,039 | +93.4% |
| Financial income | 75/76B | €159,700 | €112,668 | -€47,032 | -29.5% |
| Recurring financial income | 75 | €159,700 | €112,668 | -€47,032 | -29.5% |
| Income from current assets | 751 | €159,480 | €112,614 | -€46,866 | -29.4% |
| Other financial income | 752/9 | €220 | €54 | -€166 | -75.6% |
| Financial charges | 65/66B | €189,789 | €160,216 | -€29,573 | -15.6% |
| Recurring financial charges | 65 | €189,789 | €160,216 | -€29,573 | -15.6% |
| Debt charges | 650 | €171,723 | €156,666 | -€15,056 | -8.8% |
| Other financial charges | 652/9 | €18,067 | €3,550 | -€14,517 | -80.4% |
| Profit (loss) for the period before taxes | 9903 | €847,124 | €1,648,703 | +€801,580 | +94.6% |
| Income taxes | 67/77 | €215,721 | €424,857 | +€209,136 | +96.9% |
| Taxes | 670/3 | €215,786 | €424,857 | +€209,071 | +96.9% |
| Tax adjustments and reversals of tax provisions | 77 | €65 | - | -€65 | |
| Profit (loss) for the period | 9904 | €631,403 | €1,223,846 | +€592,444 | +93.8% |
| Profit (loss) for the period to be appropriated | 9905 | €631,403 | €1,223,846 | +€592,444 | +93.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.